The bioT3 platform

Videos - Interview with the Innovators
Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
Related Items
Introducing Genmab-Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment
Anthony Mancini, Ron Graybill
Videos published on April 15, 2022 in Interview with the Innovators
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Videos published on April 14, 2015 in Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Videos published on April 14, 2015 in Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Videos published on April 14, 2015 in Interview with the Innovators
CancerTREATMENT NGS+ in the Clinic
Ralph V. Boccia, MD, FACP
Videos published on April 14, 2015 in Interview with the Innovators
Last modified: August 30, 2021
Copyright © Engage Healthcare Communications, LLC. All rights reserved.